Combined Modality Therapy for Extensive Small-Cell Carcinoma of the Lung

Determinants of improved outcome in small cell lung cancer: An analysis of 2,580-patient Southwest Oncology Group data base.

KS Albain;JJ Crowley;M LeBlanc;RB Livingston JCO 8(9):1563-1574

Outcome of prophylactic and therapeutic cranial irradiation indisseminated small cell lung carcinoma: A Southwest Oncology Groupstudy.

JG Mira;TT Chen;RB Livingston;HE Wilson Int J Rad Oncol Biol Phys 14:861-865

Combined modality treatment of extensive small cell lung cancer. A Southwest Oncology Group study.

RB Livingston;JG Mira;TT Chen;M McGavran;JJ Costanzi;M Samson J Clin Oncol 2:585-590

Relation of relapsing sites after chemotherapy to initial sites of involvement in disseminated small cell lung carcinoma: Possible role of consolidation radiotherapy. A Southwest Oncology Group study.

JG Mira;RB Livingston;TT Chen;TN Moore;SP Balcerzak In: IASLC Workshop on Radiotherapy for Lung Cancer (Cambridge, England, July)

Outcome of prophylactic and therapeutic cranial irradiation in disseminated small lung carcinoma. A Southwest Oncology Group study.

JG Mira;TT Chen;RB Livingston;SP Balcerzak IASLC Workshop on Radiotherapy for Lung Cancer (Cambridge, England, July)

Isolated pleural effusion in small cell lung carcinoma: Favorable prognosis. A review of the Southwest Oncology Group experience.

RB Livingston;JD McCracken;CJ Trauth;TT Chen Chest 81:208-211

Influence of chest radiotherapy in frequency and patterns of chest relapse in disseminated small cell lung carcinoma: A Southwest Oncology Group study.

JG Mira;RB Livingston;TN Moore;TT Chen;F Batley;CR Bogardus;B Considine;CM Mansfield;J Schlosser;HG Seydel Cancer 50: 1266-1272

Reinduction prolongs survival in complete responders (CR) with small cell lung cancer.

RB Livingston;RL Greenstreet ASCO, #C-589

Evaluation of two different techniques for prophylactic cranial irradiation of small cell lung carcinoma.

JG Mira ASTR Poster Abstracts, p.26, #C14

Isolated pleural effusion in small cell lung carcinoma: a favorable prognostic group.

RB Livingston;JD McCracken;TT Chen AACR, #793

The value of reinduction chemotherapy in extensive small cell lung cancer.

RB Livingston;RL Greenstreet ASCO, #C-666

Non-cross-resistant combinations in patients (PTS) with extensive small cell lung cancer.

R Livingston;J Mira ASCO, #C-512